GILEAD SCIENCES, INC. Quarterly Amortization of Intangible Assets in USD from Q2 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Gilead Sciences, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2011 to Q4 2023.
  • Gilead Sciences, Inc. Amortization of Intangible Assets for the quarter ending December 31, 2023 was $558M, a 20% increase year-over-year.
  • Gilead Sciences, Inc. Amortization of Intangible Assets for the twelve months ending December 31, 2023 was $2.3B, a 27.8% increase year-over-year.
  • Gilead Sciences, Inc. annual Amortization of Intangible Assets for 2023 was $2.3B, a 27.8% increase from 2022.
  • Gilead Sciences, Inc. annual Amortization of Intangible Assets for 2022 was $1.8B, a 5.88% increase from 2021.
  • Gilead Sciences, Inc. annual Amortization of Intangible Assets for 2021 was $1.7B, a 41.7% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $2.3B $558M +$93M +20% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $2.21B $598M +$153M +34.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $2.05B $598M +$153M +34.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $1.9B $546M +$101M +22.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $1.8B $465M +$41M +9.67% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $1.76B $445M +$4M +0.91% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $1.76B $445M +$5M +1.14% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $1.75B $445M +$50M +12.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $1.7B $424M +$68M +19.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $1.63B $441M +$160M +56.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $1.47B $440M +$158M +56% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.31B $395M +$114M +40.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $1.2B $356M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $281M $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $282M -$6M -2.08% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $281M -$18M -6.02% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 $281M -$20M -6.65% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $288M -$12M -4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $299M -$2M -0.66% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q3 2018 $301M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $300M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $301M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q2 2013 $74.7M $21.5M +$5.7M +36.1% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $69M $21.5M +$5.7M +36.1% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $63.3M $15.9M Oct 1, 2012 Dec 31, 2012 10-K 2014-02-25
Q3 2012 $15.8M -$1.6M -9.2% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $15.8M -$1.6M -9.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $15.8M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q3 2011 $17.4M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $17.4M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.